Non-classical exocytosis of α-synuclein is sensitive to folding states and promoted under stress conditions

Journal of Neurochemistry

Volumn 113, Issue 5, 2010, Pages 1263-1274

  Jang, Ara ^a,b   Lee, He Jin ^a,b   Suk, Ji Eun ^b   Jung, Jin Woo ^b   Kim, Kwang Pyo ^b   Lee, Seung Jae ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Misfolding; Neurodegenerative disease; Parkinson's disease; Protein aggregation; Secretion

Indexed keywords

ALPHA SYNUCLEIN; GLOBULAR PROTEIN;

ARTICLE; CELL STRESS; CELL VACUOLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXOCYTOSIS; GOLGI COMPLEX; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NERVE CELL; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; CENTRIFUGATION; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSOL; ENDOPEPTIDASE K; EXOCYTOSIS; HUMANS; HYDROLYSIS; L-LACTATE DEHYDROGENASE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SYNTHESIS INHIBITORS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TRANSPORT VESICLES; UP-REGULATION;

EID: 77951885732     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06695.x     Document Type: Article

References (49)

1. Bamberger M. E., Harris M. E., McDonald D. R., Husemann J. Landreth G. E. (2003) A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci 23, 2665 2674. (Pubitemid 36418601)
2. Bertoncini C. W., Jung Y. S., Fernandez C. O., Hoyer W., Griesinger C., Jovin T. M. Zweckstetter M. (2005) Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc Natl Acad Sci U S A 102, 1430 1435. (Pubitemid 40209187)
3. Braak H., Del Tredici K., Rub U., de Vos R. A., Jansen Steur E. N. Braak E. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24, 197 211. (Pubitemid 36007810)
4. Conway K. A., Harper J. D. Lansbury Jr. P. T. (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39, 2552 2563.
5. Cookson M. R. (2005) The biochemistry of Parkinson's disease. Annu Rev Biochem 74, 29 52.
6. Danielsen E. M., van Deurs B. Hansen G. H. (2003) " Nonclassical" secretion of annexin A2 to the lumenal side of the enterocyte brush border membrane. Biochemistry 42, 14670 14676. (Pubitemid 37532014)
7. Davidson W. S., Jonas A., Clayton D. F. George J. M. (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273, 9443 9449. (Pubitemid 28183026)
8. Desplats P., Lee H. J., Bae E. J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E. Lee S. J. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106, 13010 13015.
9. El-Agnaf O. M., Salem S. A., Paleologou K. E., et al. (2003) Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 17, 1945 1947.
10. El-Agnaf O. M., Salem S. A., Paleologou K. E., Curran M. D., Gibson M. J., Court J. A., Schlossmacher M. G. Allsop D. (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 20, 419 425. (Pubitemid 44933318)
11. Fahn S. Sulzer D. (2004) Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx 1, 139 154. (Pubitemid 46589347)
12. Fernandez C. O., Hoyer W., Zweckstetter M., Jares-Erijman E. A., Subramaniam V., Griesinger C. Jovin T. M. (2004) NMR of alpha-synuclein- polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 23, 2039 2046. (Pubitemid 38737731)
13. Fevrier B. Raposo G. (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 16, 415 421. (Pubitemid 38903148)
14. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H. Raposo G. (2004) Cells release prions in association with exosomes. Proc. Natl Acad. Sci. USA 101, 9683 9688. (Pubitemid 38869296)
15. Fortin D. L., Nemani V. M., Voglmaier S. M., Anthony M. D., Ryan T. A. Edwards R. H. (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci. 25, 10913 10921. (Pubitemid 41692621)
16. Gardella S., Andrei C., Ferrera D., Lotti L. V., Torrisi M. R., Bianchi M. E. Rubartelli A. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 995 1001. (Pubitemid 35256475)
17. Kahle P. J. (2008) alpha-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathol. 115, 87 95. (Pubitemid 350238669)
18. Kim C. Lee S.-J. (2008) Controlling the mass action of alpha-synuclein in Parkinson's disease. J. Neurochem. 107, 303 316.
19. Kim Y. S., Laurine E., Woods W. Lee S. J. (2006) A novel mechanism of interaction between alpha-synuclein and biological membranes. J. Mol. Biol. 360, 386 397. (Pubitemid 43927829)
20. Klegeris A., Pelech S., Giasson B. I., Maguire J., Zhang H., McGeer E. G. McGeer P. L. (2008) Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol. Aging 29, 739 752. (Pubitemid 351400820)
21. Klucken J., Outeiro T. F., Nguyen P., McLean P. J. Hyman B. T. (2006) Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J. 20, 2050 2057. (Pubitemid 44953904)
22. Lauren J., Gimbel D. A., Nygaard H. B., Gilbert J. W. Strittmatter S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128 1132.
23. Lee H.-J., Khoshaghideh F., Patel S. Lee S.-J. (2004) Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 24, 1888 1896. (Pubitemid 38292800)
24. Lee H.-J., Patel S. Lee S.-J. (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. 25, 6016 6024. (Pubitemid 40911433)
25. Lee H.-J., Shin S. Y., Choi C., Lee Y. H. Lee S.-J. (2002) Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J. Biol. Chem. 277, 5411 5417. (Pubitemid 34968588)
26. Lee H.-J., Suk J. E., Bae E. J., Lee J. H., Paik S. R. Lee S.-J. (2008a) Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J. Biochem. Cell Biol. 40, 1835 1849.
27. Lee H.-J., Suk J. E., Bae E. J. Lee S.-J. (2008b) Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem. Biophys. Res. Commun. 372, 423 428.
28. Lee H. J., Suk J. E., Patrick C., Bae E. J., Cho J. H., Rho S., Hwang D., Masliah E. Lee S. J. (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 285, 9262 9272.
29. Lee S.-J. (2008) Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease. J. Mol. Neurosci. 34, 17 22.
30. Lee S. J., Lee J. R., Kim Y. H., Park Y. S., Park S. I., Park H. S. Kim K. P. (2007) Investigation of tyrosine nitration and nitrosylation of angiotensin II and bovine serum albumin with electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 21, 2797 2804.
31. Lesage S. Brice A. (2009) Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18, R48 59.
32. Nickel W. (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109 2119. (Pubitemid 36608925)
33. Outeiro T. F., Klucken J., Bercury K., Tetzlaff J., Putcha P., Oliveira L. M., Quintas A., McLean P. J. Hyman B. T. (2009) Dopamine-induced conformational changes in alpha-synuclein. PLoS One 4, e6906.
34. Poewe W. (2007) Dysautonomia and cognitive dysfunction in Parkinson's disease. Mov. Disord. 22 (Suppl. 17 S374 S378. (Pubitemid 350134191)
35. Qin Z., Hu D., Han S., Reaney S. H., Di Monte D. A. Fink A. L. (2007) Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J. Biol. Chem. 282, 5862 5870. (Pubitemid 47093740)
36. Rajendran L., Honsho M., Zahn T. R., Keller P., Geiger K. D., Verkade P. Simons K. (2006) Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl Acad. Sci. USA 103, 11172 11177. (Pubitemid 44156491)
37. Rasia R. M., Bertoncini C. W., Marsh D., Hoyer W., Cherny D., Zweckstetter M., Griesinger C., Jovin T. M. Fernandez C. O. (2005) Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson's disease. Proc. Natl Acad. Sci. USA 102, 4294 4299. (Pubitemid 40397105)
38. Reed-Geaghan E. G., Savage J. C., Hise A. G. Landreth G. E. (2009) CD14 and toll-like receptors 2 and 4 are required for fibrillar Abeta-stimulated microglial activation. J. Neurosci. 29, 11982 11992.
39. Reynolds A. D., Glanzer J. G., Kadiu I., et al. (2008) Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. J. Neurochem. 104, 1504 1525. (Pubitemid 351316759)
40. Rubartelli A., Cozzolino F., Talio M. Sitia R. (1990) A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9, 1503 1510. (Pubitemid 20137006)
41. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M. Goedert M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469 6473. (Pubitemid 28249037)
42. Su X., Maguire-Zeiss K. A., Giuliano R., Prifti L., Venkatesh K. Federoff H. J. (2008) Synuclein activates microglia in a model of Parkinson's disease. Neurobiol. Aging 29, 1690 1701.
43. Sung J. Y., Park S. M., Lee C. H., et al. (2005) Proteolytic cleavage of extracellular secreted alpha-synuclein via matrix metalloproteinases. J. Biol. Chem. 280, 25216 25224. (Pubitemid 40934615)
44. Sung Y. H., Rospigliosi C. Eliezer D. (2006) NMR mapping of copper binding sites in alpha-synuclein. Biochim. Biophys. Acta 1764, 5 12. (Pubitemid 43362825)
45. Tanudji M., Hevi S. Chuck S. L. (2002) Improperly folded green fluorescent protein is secreted via a non-classical pathway. J. Cell. Sci. 115, 3849 3857. (Pubitemid 35203611)
46. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R. Julien J. P. (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108 118. (Pubitemid 43011916)
47. Weinreb P. H., Zhen W., Poon A. W., Conway K. A. Lansbury P. T., Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709 13715. (Pubitemid 26363912)
48. Zhang W., Dallas S., Zhang D., et al. (2007) Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia 55, 1178 1188. (Pubitemid 47204209)
49. Zhang W., Wang T., Pei Z., et al. (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533 542. (Pubitemid 40471244)